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Autosomal dominant arrhythmogenic right ventricu-
lar cardiomyopathy (ARVD, MIM 107970) is one of the
major causes of juvenile sudden death. We have
previously assigned the disease locus to chromo-
some 14q23-q24. Here we report on a novel variant
of ARVD, which is transmitted associated to 1q42-
q43 and is characterized by a concealed form, show-
ing effort-induced polymorphic tachycardias. Since
both loci ARVD1 and ARVD2 map in proximity of
a-actinin genes, the possible implication of these
myofibrillar proteins in the pathogenesis of ARVD is
discussed. Two additional ARVD families, tested with
markers of chromosomes 1q42-q43 and 14q23-q24,
failed to show linkage, providing evidence of further
genetic heterogeneity.
INTRODUCTION
Arrhythmogenic right ventricular cardiomyopathy (formerly
arrhythmogenic right ventricular dysplasia, ARVD, MIM
107970) is inherited as autosomal dominant with reduced
penetrance and it is one of the major genetic causes of juvenile
sudden death (1,2).
ARVD is characterized by a degenerative process, mostly
involving the right ventricle, where the myocardium is replaced
by adipose and connective tissue (3). The presence of these
masses of fibro-fatty substitution accounts for the electrical
instability which causes ventricular arrhythmias (4).
The degenerative process extends gradually to the whole
ventricle wall, which becomes thinner than normal and in
some cases may develop ventricular aneurysms. The diagnostic
criteria of ARVD were recently established by an international
cooperative effort (5). The prevalence of the disease is estim-
ated to range from 6/10 000 in the general population to 4.4/
1000 in some areas (6). Recently, on the basis of a linkage
study on two Italian families, we assigned the ARVD locus to
chromosome 14q23-q24 (6). Here we present evidence, based
on a linkage study on three ARVD families, for the existence
of a second locus (ARVD2), carried by chromosome 1 (Iq42-
q43), and for further genetic heterogeneity.
RESULTS
In order to refine the chromosomal localization of ARVD,
three additional ARVD families were collected, one in
Switzerland (no. 101) and two in north east Italy (nos 102 and
103) (Fig. 1). The clinical features of the affected subjects
belonging to these families satisfied the current diagnostic
criteria for ARVD (5), in spite of the relevant interfamilial
variability in the manifestation of the disease.
In family 101 the clinical presentation was typical of
ARVD, with variable severity of the affection. Two subjects
encountered sudden death. Among 30 subjects which under-
went thorough cardiological study, 11 were diagnosed as
affected with ARVD; four patients snowed sustained ventricular
tachycardias with left-branch block pattern, in five cases only
minor arrhythmias were present, whereas in two other subjects
no clinical symptoms were evident before cardiological exam-
ination.
In family 102 the disease occurred in a concealed form; all
the affected members showed no change in heart size, normal
standard ECG and functional capacity, but they consistently
showed effort-induced polymorphic ventricular tachycardias.
Four cases of juvenile sudden death were reported. Post-
mortem examination of two of these subjects showed a right
ventricle of normal size, with no overt abnormalities. However
large areas of fatty-fibrous replacement, mostly localized in
the sub-epicardial layer of the right ventricle, were detected
at the histological level.
Family 103 showed one case of juvenile sudden death. Post-
mortem examination detected typical ARVD features at the
morphological and histological level. The affected subjects did
not show major ventricular arrhythmias, but they invariably
manifested a conduction defect with right branch block and
left axial deviation.
ARVD was previously located in 14q23-q24, in the same
chromosomal region where genes for a-actinin 1 and (i-spectrin
(7) were mapped. Unexpectedly, negative lod scores were
obtained in all three families tested with markers of that region
(D14S42, D14S279 and D14S254) (Table 1).
Muscle-specific a-actinin genes map to chromosome Iq42-
q43 (ACTN2) (8) and to chromosome Ilql3-ql4 (ACTN3),
respectively (8), whereas the gene coding for the non-erythroid
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Figure 1. Pedigrees of three families with recurrent arrhythmogenic right ventricular cardiomyopathy. The members of the families from whom a DNA sample
was obtained are marked by an asterisk.
Table 1. Two-point lod scores for different values of recombination fraction for three markers (D14S42, DI4S279, D14S254) of the chromosome I4q24.3 in
the three different families with recurrence of ARVD cases, reported in Fig. I
Marker
D14S42
D14S279
DI4S254
Family
101
102
103
101
102
103
101
102
103
a
b
a
b
a
b
a
b
a
b
a
b
a
b
a
b
a
b
Recombination
0.0
-2.620
-6.120
-1.581
-2.200
-1.789
-3.145
-3.122
-7.519
-0.046
-0.493
-1.448
-2.244
-2.182
-6.986
-1.702
-2.831
-1.507
-2.965
distance
0.05
-1.439
-2.424
-0.894
-1.158
-1.149
-1.286
-1.813
-3.542
-0.134
-0.364
-0.652
-1.144
-0.540
-3.009
-0.797
-1.167
-0.376
-0.577
0.10
-0.935
-1.566
-0.663
-0.774
-0.783
-0.829
-1.252
-1.993
-0.210
-0.334
-0.406
-0.745
-0.224
-1.779
-0.570
-0.826
-0.169
-0.307
0.20
-0.433
-0.746
-0.381
-0.343
-0.371
-0.380
-0.419
-0.642
-0.261
-0.265
-0.176
-0.336
0.078
-0.582
-0.301
-0.368
-0.033
-0.101
0.30
-0.180
-0.307
-0.206
-0.142
-0.152
-0.153
-0.061
-0.124
-0.196
-0.157
-0.068
-0.135
0.115
-0.132
-0.149
-0.140
-0.002
-0.032
0.40
-0.045
-0.074
-0.100
-0.070
-0.036
-0.037
0.081
0.011
-0.105
-0.083
-0.016
-0.032
0.039
-0.013
-0.071
-0.052
0.001
-0.007
Lod scores were calculated for two different values of penetrance: a = 0.7; b = 0.95
(J-spectrin (SPTBN1) maps to chromosome 2p21 (9). There-
fore, the possible linkage of ARVD with each one of these
genes was analyzed in the above families. Family 102 showed
significantly positive lod score with the marker ACTN2 (a CA
repeat polymorphism within the ct-actinin2 gene). For such a
marker, a lod score of 4.02 was obtained at 9 = 0.0, assuming
95% penetrance. The lod score resulted 3.32 at 0 = 0.0 , when
70% penetrance was assumed. The same family showed
significantly positive lod scores for markers flanking the
ACTN2 gene (Table 2). By the multipoint linkage analysis a
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Table 2. Two-point lod scores for different values of recombination fraction for seven markers (D1S178, D1SI79, D1S163, ACTN2, D1S184, D1S180 and
DISI02) of the chromosome Iq42-q43 in the family no. 102. reported in Fig. 1
Marker
D1SI78
D1SI79
D1SI63
ACTN2
D1SI84
D1SI80
DIS102
Position
Iq42-q43
Iq42-q43
Iq42-q43
Iq42-q43
Iq42-q43
Iq42-q43
Iq42-q43
a
b
a
b
a
b
a
b
a
b
a
b
a
b
Recombination fraction
0.0
0.418
0.634
2.070
2.484
3.708
4.395
3.321
4.021
3.708
4.395
-1.302
-2.483
-0.733
-1.487
0.05
0.382
0.585
1.864
2.265
3.386
4.044
3.023
3.693
3.386
4.044
-0.829
-0.985
-0.056
0.080
0.10
0.345
0.533
1.650
2.036
3.049
3.675
2.710
3.347
3.049
3.675
-0.609
-0.691
0.127
0.285
0.20
0.267
0.422
1.195
1.542
2.322
2.871
2.036
2.596
2.322
2.871
-0.356
-0.394
0.239
0.385
0.30
0.185
0.299
0.710
0.995
1.518
1.964
1.296
2.186
1.518
1.964
-0.199
-0.219
0.223
0.337
0.40
0.096
0.160
0.239
0.397
0.659
0.929
0.527
0.793
0.659
0.929
-0.087
-0.095
0.138
0.204
e m a x
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.45
0.45
0.20
0.20
^rnax
0.418
0.634
2.070
2.484
3.708
4.395
3.321
4.021
3.708
4.395
-0.041
-0.045
0.239
0.385
Lod scores were calculated for two different values of penetrance: a = 0.7; b = 0.95.
peak (5.02) was obtained in correspondence of the marker
ACTN2 (Fig. 2).
In contrast, the linkage study performed using the same
markers on families 101 and 103 produced negative lod scores.
Negative results were obtained also by using markers Dl 1S876,
INT2 and TYRSIN, flanking the location of ACTN3 (1 Iql3-
Ilql4) and D2S149, D2S162 and D2S170, which are associ-
ated to SPTBN1 (2p21) (data not shown).
DISCUSSION
In the present study, linkage was detected between ARVD and
region Iq42-q43 in one Italian family where the disease
segregated independently from markers of chromosome
14q23-q24.
The peculiar presentation of the disease in this family was
outlined in a previous paper (10). Although all the affected
subjects satisfied the current diagnostic criteria for ARVD (5),
the unusual presence of effort-induced polymorphic tachy-
cardias suggested a possible genetic heterogeneity. Linkage
data confirmed that this form is genetically different from
ARVD1. Accordingly, we suggest the name of ARVD2 for the
'concealed form showing effort-induced tachycardias'.
In family 102 ARVD2 is transmitted closely associated to
oc-actinin2. Although the 95% confidence interval is wide
(more than 20 cM), the hypothesis that a-actinin2 may be
involved in the pathogenesis of ARVD deserves consideration,
since ARVD1, in turn, was mapped within the interval of the
a-actininl locus.
Actinin-rich nemaline bodies were observed in the myo-
cardium and in the skeletal muscle of one case of fatal
cardiomyopathy, reported in a 29 year old woman showing no
neuromuscular symptoms, whose mother and one sister
suffered unexplained sudden death at ages 47 and 37 respect-
ively (11). However, the involvement of actinin in the develop-
ment of this cardiomyopathy was not proved.
Mutations in different genes coding for myofibrillar protein
are involved in the pathogenesis of familial hypertrophic
cardiomyopathy (12,13). Among myofibrillar proteins, actinins,
which belong to the spectrin superfamily, show strong structural
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Figure 2. Eight-point linkage analysis of the ARVD family no. 102, with respect
to seven marker loci. For the calculations, a 95% penetrance was assumed.
similarity with the NH2 domain of dystrophin (14). It is
noteworthy that the degenerative process taking place in the
myocardium is similar in ARVD and in Duchenne-Becker
muscular dystrophy, where a cardiomyopathy frequently
develops as a primary consequence of some dystrophin
mutations (15-17). Therefore, the involvement of actinins in
the pathogenesis of ARVD might be reasonably suspected.
However, the possibility that ARVD is caused by mutations
in a different gene, closely linked to cx-actinin, must be
seriously considered. Actinin genes are very conserved through
biological evolution (7) and multigene families are often
characterized by clustering of sequences showing high struc-
tural and functional similarity. Therefore, the existence of a
yet unknown gene, closely linked and functionally related to
actinin, cannot be excluded.
Among the two families with no linkage with markers
associated with ACTN1 or ACTN2 genes, family 103 showed
an interesting and peculiar association of ARVD with a
conduction defect. This might correspond to a new clinical
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entity. Unfortunately, a linkage simulation conducted on this
family produced a maximum expected lod score below 2.0.
Therefore the investigation on this potentially novel form of
ARVD is for the moment precluded. On the other hand, the
different manifestation of the disease in this family with respect
to family 101 indicates that the two forms may be genetically
heterogeneous. Hence, it is likely that another gene(s), in
addition to ARVD1 and ARVD2, is independently involved in
the pathogenesis of arrhythmogenic right ventricular cardio-
myopathy.
MATERIALS AND METHODS
Families
Two families with recurrence of ARVD, from the Padua district, were identified
at the Department of Cardiology of the University of Padova (Italy). Another
family, from a Swiss Alps valley, was diagnosed at the Cardiology Department
of the Luzern Kantonsspital (Switzerland).
Diagnostic criteria
International cooperation led to the establishment of diagnostic criteria for
ARVD (5). The major criteria included: familial disease diagnosed according
to autopsy or surgery, discrete myocardial atrophy with fibro-fatty replacement
of myocardium on endomyocardial biopsy, sustained left bundle branch block
type ventricular tachycardia, severe global dilatation and reduction of right
ventricular ejection fraction with no left ventricular impairment or severe
regional dilatation of the right ventricle, right ventricular aneurysms, epsilon
waves or localized prolongation (>110 ms) of the QRS in right precordial
leads (VI-V3). Minor criteria were: family history of premature sudden death
(<35 years) due to suspected right ventricular dysplasia, non-sustained left
bundle branch block type ventricular tachycardia, frequent monomorphic or
polymorphic extrasystoles left bundle branch block type, mild global right
ventricular dilatation and/or ejection fraction reduction, mild regional dilatation
of the right ventricle, regional right ventricular hypokinesia, late potentials
(signal averaged ECG), inverted T-waves in precordial leads.
Diagnosis of ARVD is fulfilled by the presence of two major criteria or
one major plus two minor criteria or four minor criteria.
Genotyping
Genomic DNA from available family members was extracted from blood
samples according to the salting out procedure. DNA samples were analyzed
by polymerase chain reaction (PCR) using markers obtained from the
Genethon list of microsatellites (18) or commercially available from ISOGEN
BIOSCIENCE TNetherlands). The amplified PCR products were denatured
and separated on a 9% denaturing polyacrylamide gel. The gels were silver
stained and dried.
Linkage analysis
The two-point linkage analyses were performed with the computer program
MLINK from the LINKAGE program (version 5.2) (19). For the multipoint
analyses the programs FASTLINK (20,21) and FASTMAP(22) were used, run
on a SUN (SPARC 10) computer.
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